Skip to main content
CivicGate

HR 1492
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Introduced Feb 21, 2025

Latest action (Feb 21, 2025) Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Referred to
Ways and Means Committee Energy and Commerce Committee
Policy area
Health
Legislative subjects (3)
Health care costs and insuranceMedicarePrescription drugs

Summary

This bill amends the Social Security Act to modify the Drug Price Negotiation Program, which allows Medicare to negotiate prices for covered drugs. Currently, biologic drugs (drugs manufactured from living organisms) receive an 11-year protection period before they can be subject to Medicare price negotiation, while small-molecule drugs (traditional pharmaceutical compounds) receive a 7-year protection period. This bill extends the protection period for small-molecule drugs from 7 years to 11 years, equalizing the negotiation timeline between the two drug categories. The change takes effect retroactively as if it were included in the original drug price negotiation law.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
68 cosponsors

Actions (2)
  1. Feb 21, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
  2. Feb 21, 2025 Introduced in House

More bills on these subjects (8)

Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).

  • HR 3164 — Ensuring Community Access to Pharmacist Services Act (shares 3 subjects)
  • HR 4077 — GUARD Veterans’ Health Care Act (shares 3 subjects)
  • HR 1476 — PLASMA Act (shares 3 subjects)
  • HR 1244 — Reducing Drug Prices for Seniors Act (shares 3 subjects)
  • HR 1227 — Alternatives to PAIN Act (shares 3 subjects)
  • HR 191 — Inflation Reduction Act of 2025 (shares 3 subjects)
  • HR 6610 — Pharmacists Fight Back [in Federal Employee Health Benefit Plans Act] (shares 2 subjects)
  • HR 1703 — Choices for Increased Mobility Act of 2026 (shares 2 subjects)

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

  • HR 1279 — To amend title XIX of the Social Security Act to establish a community engagement requirement for certain individuals under the Medicaid program. · Introduced Feb 13, 2025 · Cong. 119 76%
  • S 832 — EPIC Act of 2025 · Introduced Mar 4, 2025 · Cong. 119 70%
  • HR 1403 — LIVE Beneficiaries Act · Introduced Feb 18, 2025 · Cong. 119 69%
  • HR 1317 — I CAN Act · Introduced Feb 13, 2025 · Cong. 119 67%
  • HR 1598 — Ensuring Access to Medicaid Buy-in Programs Act · Introduced Feb 26, 2025 · Cong. 119 67%
  • HR 3079 — Medicaid Empowerment Act of 2025 · Introduced Apr 29, 2025 · Cong. 119 67%

Text versions (1)
  • Introduced in House · Feb 21, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

February 21, 2025

Mr. Murphy (for himself, Mr. Davis of North Carolina, and Mr. Hudson) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. EQUALIZING THE NEGOTIATION PERIOD BETWEEN SMALL-MOLECULE AND BIOLOGIC CANDIDATES UNDER THE DRUG PRICE NEGOTIATION PROGRAM.

(a) In General.—Section 1192(e)(1)(A)(ii) of the Social Security Act (42 U.S.C. 1320f-1(e)(1)(A)(ii)) is amended by striking “7 years” and inserting “11 years”.

(b) Effective Date.—The amendment made by subsection (a) shall take effect as if included in the enactment of Public Law 117-169. <all>

Comments

Comments

Loading comments…